REGENERON PHARMACEUTICALS (REGN) Stock Analyst Ratings
NASDAQ:REGN - Nasdaq - US75886F1075 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 79% to REGN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1093.96. This target is 62.56% above the current price.
REGN was analyzed by 34 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about REGN.
In the previous month the buy percentage consensus was at a similar level.
REGN was analyzed by 34 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-28 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-01-27 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-01-16 | UBS | Downgrade | Buy -> Neutral |
| 2025-01-14 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-01-10 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-01-08 | Truist Securities | Maintains | Buy -> Buy |
| 2025-01-07 | Bernstein | Maintains | Outperform -> Outperform |
| 2024-12-17 | Canaccord Genuity | Initiate | Hold |
| 2024-12-10 | B of A Securities | Reiterate | Underperform |
| 2024-11-15 | Wolfe Research | Initiate | Outperform |
| 2024-11-14 | Citigroup | Initiate | Neutral |
| 2024-11-06 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-11-01 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-11-01 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-01 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-01 | Truist Securities | Maintains | Buy -> Buy |
| 2024-11-01 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-11-01 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-10-25 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-10-24 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-10-24 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-10-23 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2024-10-23 | Barclays | Maintains | Overweight -> Overweight |
| 2024-10-22 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-10-22 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-10-16 | Truist Securities | Maintains | Buy -> Buy |
| 2024-10-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-09-24 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-09-24 | BMO Capital | Reiterate | Outperform -> Outperform |
| 2024-09-24 | RBC Capital | Maintains | Outperform -> Outperform |